Checkpoint Therapeutics Stock Price History
| CKPT Stock | USD 4.39 0.11 2.57% |
Below is the normalized historical share price chart for Checkpoint Therapeutics extending back to December 19, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Checkpoint Therapeutics stands at 4.39, as last reported on the 2nd of December, with the highest price reaching 4.46 and the lowest price hitting 4.21 during the day.
If you're considering investing in Checkpoint Stock, it is important to understand the factors that can impact its price. Checkpoint Therapeutics is slightly risky given 3 months investment horizon. Checkpoint Therapeutics secures Sharpe Ratio (or Efficiency) of 0.29, which signifies that the company had a 0.29% return per unit of standard deviation over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.16% are justified by taking the suggested risk. Use Checkpoint Therapeutics mean deviation of 3.2, and Risk Adjusted Performance of 0.2196 to evaluate company specific risk that cannot be diversified away.
At this time, Checkpoint Therapeutics' Common Stock Total Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 19.7 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 5.1 M in 2024. . At this time, Checkpoint Therapeutics' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 437.54 in 2024, whereas Price Earnings Ratio is likely to drop (0.87) in 2024. Checkpoint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of June 2017 | 200 Day MA 2.2947 | 50 Day MA 3.084 | Beta 1.235 |
Checkpoint |
Sharpe Ratio = 0.2909
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CKPT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.97 actual daily | 35 65% of assets are more volatile |
Expected Return
| 1.16 actual daily | 23 77% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Checkpoint Therapeutics is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Checkpoint Therapeutics by adding it to a well-diversified portfolio.
Price Book 8.5555 | Enterprise Value Ebitda (0.54) | Price Sales 2.7 K | Shares Float 34.8 M | Wall Street Target Price 17 |
Checkpoint Therapeutics Stock Price History Chart
There are several ways to analyze Checkpoint Stock price data. The simplest method is using a basic Checkpoint candlestick price chart, which shows Checkpoint Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 29, 2024 | 4.39 |
| Lowest Price | September 6, 2024 | 2.1 |
Checkpoint Therapeutics December 2, 2024 Stock Price Synopsis
Various analyses of Checkpoint Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Checkpoint Stock. It can be used to describe the percentage change in the price of Checkpoint Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Checkpoint Stock.| Checkpoint Therapeutics Price Daily Balance Of Power | 0.44 | |
| Checkpoint Therapeutics Price Action Indicator | 0.11 | |
| Checkpoint Therapeutics Price Rate Of Daily Change | 1.03 |
Checkpoint Therapeutics December 2, 2024 Stock Price Analysis
Checkpoint Stock Price History Data
The price series of Checkpoint Therapeutics for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 2.29 with a coefficient of variation of 22.96. The prices are distributed with arithmetic mean of 2.89. The median price for the last 90 days is 2.64. The company had 1:10 stock split on 6th of December 2022.| Open | High | Low | Close | Volume | ||
12/02/2024 | 4.29 | 4.46 | 4.21 | 4.39 | ||
| 11/29/2024 | 4.29 | 4.46 | 4.21 | 4.39 | 798,142 | |
| 11/27/2024 | 4.10 | 4.32 | 4.05 | 4.28 | 979,422 | |
| 11/26/2024 | 4.10 | 4.33 | 3.99 | 4.10 | 1,651,894 | |
| 11/25/2024 | 3.80 | 4.27 | 3.78 | 4.03 | 2,318,332 | |
| 11/22/2024 | 3.49 | 3.81 | 3.46 | 3.75 | 838,671 | |
| 11/21/2024 | 3.37 | 3.56 | 3.33 | 3.47 | 478,627 | |
| 11/20/2024 | 3.39 | 3.60 | 3.33 | 3.38 | 560,745 | |
| 11/19/2024 | 3.32 | 3.44 | 3.29 | 3.38 | 370,046 | |
| 11/18/2024 | 3.44 | 3.47 | 3.25 | 3.30 | 779,675 | |
| 11/15/2024 | 3.81 | 3.93 | 3.41 | 3.43 | 1,021,600 | |
| 11/14/2024 | 3.64 | 3.95 | 3.61 | 3.78 | 1,079,506 | |
| 11/13/2024 | 3.42 | 3.67 | 3.35 | 3.62 | 811,192 | |
| 11/12/2024 | 3.15 | 3.53 | 3.14 | 3.45 | 801,632 | |
| 11/11/2024 | 3.38 | 3.47 | 3.09 | 3.19 | 969,165 | |
| 11/08/2024 | 3.50 | 3.56 | 3.29 | 3.37 | 717,202 | |
| 11/07/2024 | 3.35 | 3.55 | 3.35 | 3.46 | 432,626 | |
| 11/06/2024 | 3.39 | 3.49 | 3.28 | 3.37 | 745,684 | |
| 11/05/2024 | 3.46 | 3.51 | 3.13 | 3.30 | 1,104,435 | |
| 11/04/2024 | 3.52 | 3.58 | 3.37 | 3.49 | 567,226 | |
| 11/01/2024 | 3.42 | 3.53 | 3.38 | 3.51 | 561,325 | |
| 10/31/2024 | 3.67 | 3.68 | 3.35 | 3.44 | 1,648,737 | |
| 10/30/2024 | 3.83 | 3.97 | 3.60 | 3.62 | 2,395,828 | |
| 10/29/2024 | 3.71 | 3.95 | 3.52 | 3.84 | 2,111,565 | |
| 10/28/2024 | 3.75 | 3.80 | 3.49 | 3.68 | 2,039,765 | |
| 10/25/2024 | 3.47 | 3.69 | 3.45 | 3.67 | 1,422,431 | |
| 10/24/2024 | 3.42 | 3.64 | 3.31 | 3.44 | 2,030,803 | |
| 10/23/2024 | 3.16 | 3.50 | 3.13 | 3.41 | 1,642,012 | |
| 10/22/2024 | 3.24 | 3.29 | 3.08 | 3.16 | 935,164 | |
| 10/21/2024 | 3.02 | 3.25 | 2.99 | 3.18 | 1,164,775 | |
| 10/18/2024 | 3.00 | 3.10 | 2.92 | 3.01 | 802,665 | |
| 10/17/2024 | 2.90 | 3.10 | 2.84 | 2.97 | 1,014,985 | |
| 10/16/2024 | 2.69 | 2.97 | 2.65 | 2.82 | 1,206,046 | |
| 10/15/2024 | 2.52 | 2.70 | 2.37 | 2.64 | 651,501 | |
| 10/14/2024 | 2.44 | 2.66 | 2.42 | 2.54 | 783,324 | |
| 10/11/2024 | 2.35 | 2.52 | 2.35 | 2.44 | 194,115 | |
| 10/10/2024 | 2.34 | 2.40 | 2.30 | 2.37 | 194,309 | |
| 10/09/2024 | 2.38 | 2.44 | 2.31 | 2.34 | 201,434 | |
| 10/08/2024 | 2.48 | 2.54 | 2.34 | 2.37 | 586,708 | |
| 10/07/2024 | 2.23 | 2.49 | 2.23 | 2.44 | 1,038,161 | |
| 10/04/2024 | 2.22 | 2.23 | 2.18 | 2.22 | 247,458 | |
| 10/03/2024 | 2.23 | 2.24 | 2.16 | 2.18 | 358,724 | |
| 10/02/2024 | 2.20 | 2.25 | 2.18 | 2.24 | 312,990 | |
| 10/01/2024 | 2.24 | 2.26 | 2.17 | 2.19 | 237,872 | |
| 09/30/2024 | 2.25 | 2.29 | 2.18 | 2.24 | 197,410 | |
| 09/27/2024 | 2.23 | 2.27 | 2.19 | 2.25 | 297,606 | |
| 09/26/2024 | 2.25 | 2.25 | 2.14 | 2.23 | 322,984 | |
| 09/25/2024 | 2.29 | 2.31 | 2.20 | 2.24 | 352,707 | |
| 09/24/2024 | 2.38 | 2.39 | 2.20 | 2.22 | 734,992 | |
| 09/23/2024 | 2.38 | 2.44 | 2.32 | 2.36 | 383,254 | |
| 09/20/2024 | 2.46 | 2.47 | 2.34 | 2.41 | 438,075 | |
| 09/19/2024 | 2.55 | 2.60 | 2.40 | 2.43 | 331,734 | |
| 09/18/2024 | 2.54 | 2.57 | 2.42 | 2.46 | 534,304 | |
| 09/17/2024 | 2.40 | 2.58 | 2.39 | 2.52 | 850,283 | |
| 09/16/2024 | 2.31 | 2.42 | 2.25 | 2.34 | 499,002 | |
| 09/13/2024 | 2.21 | 2.36 | 2.21 | 2.30 | 321,156 | |
| 09/12/2024 | 2.23 | 2.27 | 2.17 | 2.19 | 111,897 | |
| 09/11/2024 | 2.15 | 2.22 | 2.12 | 2.21 | 177,882 | |
| 09/10/2024 | 2.10 | 2.15 | 2.06 | 2.14 | 289,919 | |
| 09/09/2024 | 2.09 | 2.17 | 2.09 | 2.13 | 202,130 | |
| 09/06/2024 | 2.16 | 2.20 | 2.06 | 2.10 | 389,360 |
About Checkpoint Therapeutics Stock history
Checkpoint Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Checkpoint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Checkpoint Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Checkpoint Therapeutics stock prices may prove useful in developing a viable investing in Checkpoint Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 18.7 M | 19.7 M | |
| Net Loss | -51 M | -48.5 M |
Checkpoint Therapeutics Stock Technical Analysis
Checkpoint Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Checkpoint Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Checkpoint Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Checkpoint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Checkpoint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2196 | |||
| Jensen Alpha | 1.07 | |||
| Total Risk Alpha | 0.4337 | |||
| Sortino Ratio | 0.261 | |||
| Treynor Ratio | 3.51 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Checkpoint Stock Analysis
When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.